Candida-Infektionen in der Intensivmedizin

Anaesthesist

Volumn 45, Issue 2, 1996, Pages 195-210

  Presterl, E ^a,c   Lassnigg A ^b   Willinger, B ^c   Graninger, W ^a  

^a Univ Klin für Inn Medizin I

^b Univ Klin Anaesthesie Allg I

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CANDIDA ALBICANS; CLINICAL FEATURE; DIAGNOSIS; DRUG INFORMATION; DRUG THERAPY; ETIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; PREVENTION; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; THROMBOCYTOPENIA;

CANDIDIASIS; HUMANS; INTENSIVE CARE;

EID: 0030040099     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wey SB, Mori M, Pfaller MA, Wolson RF, Wenzel RP (1979) Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149:2349-2353
2. Komshian SV, Wadah AK, Sobel JD, Crane LR (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 3:379-390
3. Banerjee SN, Emori TG, Culver DH (1991) Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 91 (S3):86S-89S
4. Beck-Sangue CM, Jarvis WR and the National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the US 1980-1990. J Infect Dis 167:1247-1251
5. Odds FC (1987) Candida infections: an overview. Crit Rev Microbiol 15:1-5
6. Wade JC (1993) Epidemiology of Candida infections. In: Bodey GP (ed) Candidiasis. New York, Raven Press
7. Pfaller MA (1987) Strain variation among Candida species: application of various typing methods to study the epidemiology and pathogenesis of candidiasis in hospitalized patients. Inf Control 8:273-276
8. Bodey G (1993) Hematogenous and major organ candidiasis. In: Bodey GP (ed) Candidiasis. New York, Raven Press
9. Masur H, Rosen PP, Armstrong D (1977) Pulmonary disease caused by Candida species. Am J Med 63:914-25
10. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey G (1988) Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 94:745-9
11. Moyer DV, Edwards JE (19 Candida endophthalmitis and central nervous system infection. In: Bodey GP (ed) Candidiasis. New York, Raven Press
12. Hallum JL, Williams TW Candida endocarditis. In: Bodey GP (ed) Candidiasis. New York, Raven Press
13. Bernhardt HE, Orlando JC, Benfield JR, Hirose FM, Foos RY (1972) Disseminated candidiasis in surgical patients. Surg Gynecol Obstet 143:819-825
14. Soutter DI, Todd RR J (1986) Systemic candidiasis in a surgical intensive care unit. Can J Surg 29:197-199
15. Solomkin J, Flohr A, Quie PG, Simmons RL (1980) The role of Candida sp. in intraperitoneal infections. Surgery 88:524-530
16. Burchard KW, Minor LB, Slotman GJ, Gann DS (1983) Fungal sepsis in surgical patients. Arch Surg 118:217-221
17. Dummer JS, Hardy A, Poorsatter A, Ho M (1983) Early infections in kidney. heart and liver transplant recipients on cyclosporine. Transplantation 36: 259-267
18. Howard RJ, Simmons RL, Najarian JS (1978) Fungal infections in renal transplant recipients. Ann Surg 187:126-133
19. Wajszczuk CP, Dummer JS, Ho M. Van Theil DH, Sarnzl TE, Iwatsuki S, Shaw B (1985) Fungal infections in liver transplant recipients. Transplantations 49:347-353
20. Verfaillie C, Weisdorf D, Haake R, Hofstetter M, Mansay NKC, McGlave P (1991) Candida infections in bone marrow recipients. Bone marrow transplantations 8:177-184
21. Gallis HA, Berman RA, Cate TR , Hamilton JD , Gunnellls JC, Stickel DL (1975) Fungal infection following renal transplantation. Arch Intern Med 135:1163-1175
22. Fox BC, Sollinger HW, Beizer FO, Maki DG (1990) A prospective, randomized double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantion clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 89:255-274
23. Wingard JR, Merz WG, Rinaldi MG, Johnson TT, Karp JE, Saral R (1991) Increase of Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277
24. Walsh T (1993) Laboratory diagnosis of candidiasis In: Bodey GP (ed) Candidiasis. New York, Raven Press
25. Jones JJ (1990) Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 3:32-41
26. Kealey GP, Heinle JA, Lewis RW, Pfaller MA, Rosenquist MD (1992) Value of the Candida antigen assay in the diagnosis of systemic candidiasis in burn patients. J Trauma 32:285-288
27. Walsh TJ, Hathorn JW, Sobel JD et al (1991) Detection fo circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis New England J Med 3241026-1031
28. Gutierrez J, Maroto C, Piedrola G, Martin E, Perez JA (1993) Circulating Candida antigens and antibodies: Useful markers of candidemia. J Clin Microbiol 31:2550-2552
29. Fujita S, Maeno K, Soyama K (1989) Mannan und D-arabinitol concentrations in serum from a patient with Candida albicans endocarditis. Mycopathologia 105:87-92
30. Tokunaga S, Ohkawa M, Takashima M, Seto C, Nakamura S (1995) D-arabinitol versus mannan antigen und candidal protein antigen as serum marker for Candida pyelonephritis. Eur J Clin Microbiol Infect Dis 14:118-121
31. Fridrik MA, Wahl G, Grafinger-Witt E, Leisen F (im Druck) Efficacy and toxicity of a rapid amphotericine B saturation in neutropenic patients
32. Fisher MA, Talbot GH, Maislin G, McKeon BP, Tynan KP, Strom BL (1989) Risk factors for amphotericine B-associated nephrotoxicity. Am J Med 87: 547-552
33. Schmitt HJ (1993) New methods of delivery of amphotericin. B Clin Infect Dis 17 (Suppl 2):501-506
34. Pahls S, Schaffner A (1994) Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. J Infect Dis 169:1057-1061
35. Arning M, Heer-Sonderhoff AH, Wehmeier A, Schneider W (1995) Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia. Eur J Clin Microbiol Infect Dis 14:41-43
36. Mills W, Chopra R, Linch C, Goldstone AH (1994) Lipsomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-centre experience of 133 episodes in 116 patients. Brit J Haematol 86:754-760
37. Emminger W, Graninger W, Emminger-Schmidmeier W (1994) Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer. Ann Haematol 68:27-31
38. Graybill JR, Sharkey-Mathis PK (1992) New antifungal agents. Current Opinions Infect Dis 5:773-780
39. Ferrer M, Torres A, Gonzales J, Puig dela Bellacasa J, el Ebiary M (1994) Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 120:389-95
40. Dever LL, Johanson WG (1993) An update on selective decontamination of the digestive tract. Current Opinions Infect Dis 6:744-750
41. White M H (1993) Antifungal prophylaxis. Current Opinions Infect Dis 6: 737-743
42. Beyer J, Schwartz S, Heinemann V, Siegert W (1994) Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimier Agents Chemother 38:911-917
43. Damjanovic V, Connolly CM, van Saene HK et al (1993) Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24:245-259
44. Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M (1992) Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared to amphotericin B. Ann Intern Med 14:422-426
45. Denning DW, Donelly JP, Hellreigel KP, Ito J, Martino P, van't Wout JW (1992) Antifungal prophylaxis during neutropenia or allogenic hone marrow transplantation: What is the state of the art? Chemotherapy 38 (Suppl 1):43-49
46. Rex JH, Bennett JE , Sugar AM, Pappas PG, Van der Horst CH for the Candidemia Study Group and National Institute of Allergiy and Infectious Diseases Mycoses Study Group (1994) A randomized trial comparing fluconazole and amphotericin B for the treatment of candidemia in patients without neutropenia. New Engl J Med 331:1325-1330
47. Winston DJ , Chandrasekar PH , Lazarus HM, Goodman JL (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Ann Intern Med 118:495-503